Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Market Cap	31.80B
Revenue (ttm)	47.37B
Net Income (ttm)	2.65B
Shares Out	15.23M
EPS (ttm)	171.74
PE Ratio	12.16
Forward PE	13.04
Dividend	70.00 (3.34%)
Ex-Dividend Date	May 29, 2025

Volume	20,100
Average Volume	29,300
Open	2,150.00
Previous Close	2,150.00
Day's Range	2,094.00 - 2,150.00
52-Week Range	1,992.00 - 2,573.00
Beta	0.19
RSI	54.20
Earnings Date	Apr 10, 2025

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 1,070
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4577

Financial Performance

In 2024, Daito Pharmaceutical's revenue was 46.90 billion, an increase of 3.98% compared to the previous year's 45.10 billion. Earnings were 3.30 billion, a decrease of -8.47%.